I'm of a different opinion. The FDA will want to see safety of our device. Therefore the number of DurAvr's will be similar to competitor trials ie 800-900. Trying to get 300 in a non inferiority trial is clever sneaky but doubt the FDA will allow such low DurAvrs numbers.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.49 |
Change
-1.110(8.81%) |
Mkt cap ! $191.9M | |||
| Open | High | Low | Value | Volume |
| $11.95 | $11.95 | $11.01 | $134.8K | 11.78K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 60 | $11.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.49 | 2949 | 1 |
View Market Depth
| Last trade - 16.10pm 25/02/2025 (20 minute delay) ? |
| AVR (ASX) Chart |